Menu
GeneBe

PRXL2B

peroxiredoxin like 2B

Basic information

Region (hg38): 1:2586490-2591469

Previous symbols: [ "C1orf93", "FAM213B" ]

Links

ENSG00000157870NCBI:127281HGNC:28390Uniprot:Q8TBF2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRXL2B gene.

  • Inborn genetic diseases (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRXL2B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
2
clinvar
2
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
6
clinvar
6
Total 0 0 8 0 0

Variants in PRXL2B

This is a list of pathogenic ClinVar variants found in the PRXL2B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-2586800-G-A not specified Uncertain significance (Mar 02, 2023)2458118
1-2586800-G-T not specified Uncertain significance (Jun 07, 2023)2559233
1-2586814-T-G not specified Uncertain significance (Dec 05, 2022)3220088
1-2586824-A-C not specified Uncertain significance (Jan 26, 2022)3220089
1-2586835-G-T not specified Uncertain significance (Sep 06, 2022)3220090
1-2586905-C-T not specified Uncertain significance (Dec 19, 2022)3220086
1-2586937-G-C not specified Uncertain significance (Oct 27, 2022)3220087
1-2587213-C-G not specified Uncertain significance (Feb 07, 2023)2481486
1-2588365-G-A not specified Uncertain significance (Dec 07, 2023)3220091
1-2588550-G-T not specified Uncertain significance (Jun 11, 2021)3220092
1-2588970-A-G not specified Uncertain significance (Mar 29, 2023)2524992
1-2588972-G-A not specified Uncertain significance (Aug 08, 2022)3220095
1-2589005-A-G not specified Uncertain significance (Dec 14, 2023)3220096
1-2589029-G-A not specified Likely benign (Dec 06, 2021)3220097
1-2591019-G-A not specified Uncertain significance (Aug 16, 2022)2231279
1-2591027-G-T not specified Uncertain significance (Mar 11, 2024)3219778
1-2591034-G-A not specified Uncertain significance (Sep 17, 2021)2364602
1-2591042-T-C not specified Uncertain significance (Aug 17, 2022)2308353
1-2591044-G-T not specified Uncertain significance (Dec 17, 2023)3219682
1-2591055-C-T not specified Uncertain significance (Aug 30, 2021)2409143

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRXL2Bprotein_codingprotein_codingENST00000419916 74979
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001510.43012545502851257400.00113
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.354971070.9040.000005701421
Missense in Polyphen3035.2740.85048401
Synonymous0.1205051.10.9790.00000298483
Loss of Function0.42689.410.8504.02e-7124

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.01050.0105
Ashkenazi Jewish0.003180.00318
East Asian0.0001090.000109
Finnish0.00004620.0000462
European (Non-Finnish)0.0005300.000528
Middle Eastern0.0001090.000109
South Asian0.0002360.000229
Other0.0006520.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha) (By similarity). {ECO:0000250}.;

Intolerance Scores

loftool
rvis_EVS
-0.01
rvis_percentile_EVS
53.19

Haploinsufficiency Scores

pHI
0.126
hipred
N
hipred_score
0.239
ghis
0.559

Mouse Genome Informatics

Gene name
Fam213b
Phenotype

Gene ontology

Biological process
prostaglandin biosynthetic process;oxidation-reduction process;cellular oxidant detoxification
Cellular component
cytoplasm;endoplasmic reticulum;cytosol;myelin sheath;extracellular exosome
Molecular function
antioxidant activity;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;prostaglandin-F synthase activity